Results 141 to 150 of about 48,363 (248)

Evaluation of evolocumab on saphenous vein graft patency following coronary artery bypass graft surgery in people living with and without diabetes in the NEWTON‐CABG CardioLink‐5 trial

open access: yes
Diabetes, Obesity and Metabolism, Volume 28, Issue 5, Page 4376-4381, May 2026.
Hwee Teoh   +14 more
wiley   +1 more source

Research on System Partition Method for EMUs Based on Analytic Hierarchy Process and Genetic Algorithm

open access: yes机车电传动, 2017
A system partition method based on modular theory for EMUs was presented. By considering the basic properties of EMUs components function and application, with the relevant relations definition among components, a comprehensive relation matrix was ...
Zhang Kexin
doaj  

Revisiting Assisted Reproductive Technology (ART) - Related Psychological Symptom Clusters [Letter]

open access: yesInternational Journal of Women's Health
Huimin Du,1 Kexin Wang2 1First Affiliated Hospital of Huzhou University, Huzhou, Zhejiang People’s Republic of China; 2Gynecology Department, People’s Hospital of Xinjiang Uygur Autonomous Region, Urumchi, People’s Republic of ...
Du H, Wang K
doaj  

[Proprotein convertase subtilisin/kexin type 9 (PCSK9) and inhibitors].

open access: yesTurk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir, 2015
Hypercholesterolemia is a major risk factor for atherosclerosis. Low-density lipoprotein cholesterol (LDL-C) lowering drugs reduce cardiovascular morbidity and mortality. However, many individuals treated with statins do not achieve their target levels of LDL-C.
Ahmet, Avci   +2 more
openaire   +1 more source

GmRPS5 Promoter‐Driven CRISPR/LbCas12a Efficiently Generates Soybean Sextuple Mutants

open access: yes
Plant Biotechnology Journal, Volume 24, Issue 5, Page 3494-3496, May 2026.
Xiangchao Kong   +6 more
wiley   +1 more source

Leptin, Resistin, and Proprotein Convertase Subtilisin/Kexin Type 9 [PDF]

open access: yesThe American Journal of Pathology, 2020
Chiara Macchi   +13 more
openaire   +1 more source

Home - About - Disclaimer - Privacy